相关实验视频

Updated: May 26, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

卡切西亚是肝细胞癌患者在全身向治疗中的死亡率的独立预测因子

Shinji Unome¹, Kenji Imai¹, Masashi Aiba¹

¹Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan.

Clinical nutrition ESPEN

|February 24, 2025

概括

在接受向治疗的不可切除的肝细胞癌 (HCC) 患者中,舌症很常见. 鉴定缓解症预测整体存活率和进展后存活率较差,有助于患者管理.

科学领域:

在瘤学瘤学.
肝病学肝病学是一种肝病学.
临床医学临床医学

背景情况:

不切除的肝细胞癌 (HCC) 带来了重大管理挑战.
系统性向治疗是晚期HCC的关键治疗方式.
卡切西亚是一种复杂的代谢综合征,影响癌症患者.

研究的目的:

为了确定在接受全身向治疗的HCC患者中白血病的患病率.
评估卡切西亚对生存结果的预后意义.
识别卡赫西亚作为HCC患者管理中的潜在因素.

主要方法:

对200名无法切除的HCC患者接受全身向治疗的回顾性分析.
基于新的2023年标准进行卡切西亚诊断.
预测影响使用考克斯比例危险模型进行评估.

主要成果:

在35%的患者中发现了,与较高的des-gamma-carboxy prothrombin和肝外传播有关.
抑郁症患者的整体存活时间显著缩短 (14.1 vs 20.9 个月) 和进展后的存活时间 (4.8 vs 11.1 个月).
卡切西亚独立预测了较差的整体和进展后生存率 (HR分别为1.54和1.64).

结论:

在接受向治疗的HCC患者中,甲状腺是普遍存在的,是低生存率的独立预测因素.
早期评估缓解症对于优化HCC的管理策略至关重要.
研究结果支持将缓解症评估纳入常规HCC护理.

关键词:

卡切西亚卡切西亚肝细胞癌是肝细胞癌.总体生存率总体生存率进展后的生存率.系统性向治疗的系统性向治疗.

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...